ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 576 • 2013 ACR/ARHP Annual Meeting

    Monitoring Of Opportunistic Virus Infections In Systemic Lupus Erythematosus

    Lorenzo Cavagna1, Sandra Calarota2, Eva Scorletti3, Roberto Caporali4, Francesca Rovida5, Carlomaurizio Montecucco1 and Fausto Baldanti5, 1Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, 2Molecular Virology Unit, Virology and Microbiology Department, IRCCS Foundation Policlinico S. Matteo, Pavia, Italy, 3Division of Rheumatology, University and IRCCS Foundation Policlinico S. Matteo, Pavia, Italy, 4Division of Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, 5Molecular Virology Unit, Virology and Microbiology Department, IRCCS Foundation Policlinico S. Matteo,, Pavia, Italy

    Background/Purpose: due to disease characteristics and treatment approaches, systemic lupus erythematosus (SLE) patients are at high risk of opportunistic virus infections, as for example Epstein…
  • Abstract Number: 577 • 2013 ACR/ARHP Annual Meeting

    Is An Excess Risk Of Attention Deficit Hyperactivity Disorder In Children Born To Women With SLE Mediated By In Utero Drug Exposures? Preliminary Data From The O S L E R Cohort

    Evelyne Vinet1, Susan Scott2, Christian A. Pineau3, Lawrence Joseph4, Ann E. Clarke5, Eric Fombonne6, Robert W. Platt4 and Sasha Bernatsky7, 1McGill University Health Center, Montreal, QC, Canada, 2McGill University Health Centre, Montreal, QC, Canada, 3Rheumatology, McGill University Health Center, Montreal, QC, Canada, 4McGill University, Montreal, QC, Canada, 5Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, 6Oregon Health and Sciences University, Portland, OR, 7Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada

    Background/Purpose: Women with SLE display autoantibodies (e.g. anti-N-methyl-D-aspartate receptor antibodies) and cytokines (e.g. interleukin-6), which, in animal models, alter fetal brain development and induce behavioural…
  • Abstract Number: 578 • 2013 ACR/ARHP Annual Meeting

    Ultrasonographic Findings and Inter-Observer Reliability In Danish Patients With Systemic Lupus Erythematosus – a Comparison With Clinical Examination Of Wrist and Hand Joints

    Lene Dreyer1, Søren Jacobsen2, Lars Juul3 and Lene Terslev4, 1Internal Medicine - Rheumatology Section, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, 2Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 3Department of Rheumatology, Copenhagen University Hospital at Gentofte, Copenhagen, Denmark, 4Copenhagen University Hospital at Glostrup, Copenhagen, Denmark

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) frequently encounter problems of musculoskeletal origin including arthralgia, tenosynovitis and arthritis in varying degrees of severity. Some patients…
  • Abstract Number: 545 • 2013 ACR/ARHP Annual Meeting

    Preferential Infiltration Of Double-Negative (DN) T Cells Into The Glomeruli Of NZM 2328 Lupus Mice

    Ning Yu, Shunhua Guo, William Stohl and Chaim O. Jacob, Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Lupus nephritis affects at least 50% of patients with SLE and is a major cause of morbidity. The pathologic picture of lupus nephritis is…
  • Abstract Number: 542 • 2013 ACR/ARHP Annual Meeting

    Evidence For Involvement Of C5a Receptor in Human and Murine Lupus Nephritis

    Constanze Hess1, Ditte Tornehave2, Peter Helding Kvist2, Yvonne Sundström3, Louise Berg3, Iva Gunnarsson4, Søren Jacobsen5, Claus Haase1 and Lars Hornum1, 1Department of Immunopharmacology, Novo Nordisk A/S, Måløv, Denmark, 2Department of Histology, Novo Nordisk A/S, Måløv, Denmark, 3Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 4Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 5Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

    Background/Purpose: The complement system plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Apart from the activation of the early components of…
  • Abstract Number: 543 • 2013 ACR/ARHP Annual Meeting

    Inhibiting TWEAK (TNF-like weak inducer of apoptosis) Signaling Improves Blood Brain Barrier Integrity and Protects From Neuronal Damage In Murine Neuropsychiatric Lupus

    Jing Wen1, Jessica Doerner2, Ariel Stock1, Jennifer Michaelson3, Linda Burkly3, Maria Gulinello1 and Chaim Putterman4, 1Albert Einstein College of Medicine, Bronx, NY, 2Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, 3Biogen Idec, Cambridge, MA, 4The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by involvement of multiple organs, including the central nervous system. While neuropsychiatric involvement in…
  • Abstract Number: 544 • 2013 ACR/ARHP Annual Meeting

    Ultraviolet-B Induced Plasmacytoid Dendritic Cell Migration and Type 1 Interferon Signaling In The Skin

    Clayton Sontheimer1, Thomas H. Teal2, Nalini Agrawal2, Denny Liggitt3 and Keith B. Elkon4, 1Pediatric Rheumatology, University of Washington, Seattle, WA, 2Rheumatology, University of Washington, Seattle, WA, 3Comparative Medicine, University of Washington, Seattle, WA, 4Department of Medicine & Immunology, University of Washington, Seattle, WA

    Background/Purpose: Plasmacytoid dendritic cells (pDCs) are highly specialized cells of the innate immune system that secrete very high levels of interferon alpha (IFN-a) following nucleic…
  • Abstract Number: 546 • 2013 ACR/ARHP Annual Meeting

    The Survival Of Gr1+CD11b+ cells Is Differentially Regulated In Male and Female Lupus-Prone Mice

    Elena Gonzalez1,2, Trine Jorgensen2 and Abhishek Trigunaite2, 1Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, 2Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Systemic Lupus Erythematosis (SLE) is a multisystem autoimmune disease that develops far more frequently in females than in males (9:1 ratio). The (NZBxNZW)F1 lupus-prone…
  • Abstract Number: 547 • 2013 ACR/ARHP Annual Meeting

    Anti Ribosomal P  Antibodies Accelerate Lupus Glomerulonephritis and Induce Lupus Nephritis In Naive Mice

    Dana Ben-Ami Shor1, Miri Blank2, Sandra Reuter3, Torsten Matthias4, Alexander Volkov5, Iris Barshack6 and Yehuda Shoenfeld7, 1Zabludowicz Center for Autoimmune Diseases, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Israel, 2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to Sackler Faculty of Medicine,Tel Aviv University, Tel-Aviv, Tel-Aviv, Israel, 3AIRA e.V., AESKU.KIPP Institute, Wendelsheim, Germany, 4AESKU.Diagnostics GmbH & Co. KG, Wendelsheim, Germany, 5Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Tel-Aviv, Israel, 6Institute of Pathology, Sheba Medical Center, affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel, 7Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Circulating anti-phosphoribosomal protein antibodies (anti-Ribos.P) were found to be associated with lupus nephritis. We have assessed the direct role of anti-Ribos.P in the development…
  • Abstract Number: 548 • 2013 ACR/ARHP Annual Meeting

    Characterizing The Role Of The Granulocyte Colony Stimulating Factor Pathway In a Mouse Model Of Systemic Lupus Erythematosus

    Laurence Morel1 and Ramya Sivakumar2, 1Pathology/Immunology/Lab Medical, University of Florida, Gainesville, FL, 2Pathology, University of Florida, Gainesville, FL

    Background/Purpose: Originally considered primarily a B cell disorder, lupus pathogenicity has recently been linked to enhanced functions of neutrophils. The genetic analysis of the lupus…
  • Abstract Number: 549 • 2013 ACR/ARHP Annual Meeting

    Augmented Megakaryopoiesis Supports Accumulation Of Plasma Cells In Lupus-Prone Mice

    Oliver Winter1, Niels-Peter Becker2, Stephanie Musiol2, Katrin Moser3, Falk Hiepe4 and Rudolf A. Manz5, 1Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany, 2Charité - University Medicine Berlin, Berlin, Germany, 3German Arthritis Research Center (DRFZ Berlin), Berlin, Germany, 4Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany, 5Institute for Systemic Inflammation Research (ISEF), University of Lübeck, Lübeck, Germany

    Background/Purpose: Autoantibodies - secreted by short- and long-lived plasma cells in bone marrow and spleen - trigger the immune response, and immune complex deposits in…
  • Abstract Number: 550 • 2013 ACR/ARHP Annual Meeting

    Neutrophil Gelatinase Associated Lipocalin (NGAL/Lipocalin-2) Regulates the  Onset Of Serum Autoantibodies In Pristane Induced Lupus

    Rahul Pawar1, Beatrice Goilav2, Yumin Xia1, Haoyang Zuang3, Leal Herlitz4, Westley H. Reeves5 and Chaim Putterman6, 1Albert Einstein College of Medicine, Bronx, NY, 2Division of Nephrology, Children's Hospital at Montefiore, Bronx, NY, 3University of Florida, Gainesville, FL, 4The Department of Pathology, Columbia University Medical Center, New York, NY, 5Medicine, University of Florida, Gainesville, FL, 6The Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: NGAL (lipocalin-2), a member of the lipocalin superfamily, is expressed by a variety of cells including neutrophils, hepatocytes, alveolar epithelial cells and renal resident…
  • Abstract Number: 551 • 2013 ACR/ARHP Annual Meeting

    Different Cell Death Programs Contribute To Severity Of Lupus Glomerulonephritis In Males and Females

    Neelakshi Jog1 and Roberto Caricchio2, 1Rheumatology, Temple University, Philadelphia, PA, 2Medicine/Rheumatology, Temple University, Philadelphia, PA

    Background/Purpose: Lupus glomerulonephritis (GN) is a leading cause of long-term disability in SLE. Although lupus is more common in females, GN occurs earlier and in…
  • Abstract Number: 552 • 2013 ACR/ARHP Annual Meeting

    Inhibitor Of Differentiation 3, A Transcription Factor Regulates Susceptibility To Kidney Disease

    Dominika Nackiewicz1, Ani Manichaikul2, Barbara Szczerba3, Paromita Dey3, Stephen Rich2, Coleen McNamara4, Umesh Deshmukh1 and Harini Bagavant3, 1Medicine, University of Virginia, Charlottesville, VA, 2Center for Public Genomics, University of Virginia, Charlottesville, VA, 3Department of Medicine, University of Virginia, Charlottesville, VA, 4University of Virginia, Charlottesville, VA

    Background/Purpose: Responses of renal cells to pathogenic stimuli play an important role in dictating susceptibility to kidney disease.  Inhibitor of differentiation 3, ID3, is a…
  • Abstract Number: 553 • 2013 ACR/ARHP Annual Meeting

    Estrogen Receptor Alpha Deficiency Protects Against Development Of Cognitive Impairment In Murine Lupus

    Melissa A. Cunningham1, Jena Wirth1, Heather A. Boger2, Ann-Charlotte Granholm-Bentley3 and Gary S. Gilkeson4, 1Med/Rheumatology, MUSC, Charleston, SC, 2Neuroscience, Medical University of SC, Charleston, SC, 3Neuroscience, MUSC, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Up to 80% of SLE patients have cognitive defects or affective disorders. The mechanism of CNS injury responsible for cognitive impairment is unknown.  Anti-dsDNA…
  • « Previous Page
  • 1
  • …
  • 2210
  • 2211
  • 2212
  • 2213
  • 2214
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology